ライフサイエンスコーパス: Japanese population

1 cohort pattern of H. pylori infection in the Japanese population.

2 343A variant was exclusively observed in the Japanese population.

3 2 polymorphisms were associated with BD in a Japanese population.

4 ously reported to be associated with RA in a Japanese population.

5 the asporin gene was recently reported in a Japanese population.

6 eptibility to rheumatoid arthritis (RA) in a Japanese population.

7 esity and periodontal disease was found in a Japanese population.

8 identical to ancestral haplotype 7.2 in the Japanese population.

9 e, underlying infection in a community-based Japanese population.

10 dataset that covers approximately 2% of the Japanese population.

11 were originally thought to be unique to the Japanese population.

12 loss of activity, which occurs in 4% of the Japanese population.

13 fine-scale mapping of a rare disease in the Japanese population.

14 ustralian populations, was not found in this Japanese population.

15 heterozygous trait is present in 27% in the Japanese population.

16 g ethnicities, which was most evident in the Japanese population.

17 ucted a meta-analysis of GWAS for T2D in the Japanese population.

18 a poor response to latanoprost in a healthy Japanese population.

19 n, found with small frequency in Chinese and Japanese populations.

20 (kidney stones) in the Northern European and Japanese populations.

21 DQA1-DQB1 data from Caucasian, African, and Japanese populations.

22 uated in cohorts from the CEPH, African, and Japanese populations.

23 rge-scale meta-analysis of two GWAS from the Japanese population (1,583 cases and 3,386 controls) and

24 g analysis of rheumatoid arthritis (RA) in a Japanese population (6,244 RA cases and 23,731 controls)

25 y associated with atrial fibrillation in the Japanese population after comparing our data to those fr

26 This SNP is common (>18%) in the Japanese population and indicates that the increased sen

27 activation, confers susceptibility to KD in Japanese populations and increases the risk of developin

28 1; SLC22A4) gene was associated with RA in a Japanese population, and a haplotype of a different SNP

29 ommon autosomal recessive diseases among the Japanese population, and yet few patients outside of Jap

30 inese and the Japanese populations, with the Japanese population being the less diverse.

31 nt is present at a frequency of 23.7% in the Japanese population but is absent in Caucasoids.

32 This preference applied across UK and Japanese populations but was stronger for within-populat

33 was effective for imputing genotypes of the Japanese population genome wide.

34 In the Japanese population, half of the cases analyzed appear t

35 Candidate gene studies in the Japanese population have implicated signal transducer an

36 Prospective cohort studies in Japanese populations have shown an inverse association b

37 eptibility haplotype associated with RA in a Japanese population is not associated with RA in a UK po

38 A random Japanese population (n = 129) and a collection of multie

39 elation to atopic and non-atopic asthma in a Japanese population (n = 400).

40 A recent study in a Japanese population of Kawasaki disease patients at high

41 y Japanese individuals and construction of a Japanese population reference panel (1KJPN).

42 Further characterization of a Japanese population shows that at least part of the incr

43 ugh 52.6% (51 of 97) of the samples from the Japanese population tested had very high antibody titers

44 As in the Japanese population, the SNPs in the UK population defin

45 In contrast to studies in Japanese populations, this study did not show a statisti

46 The status of IPF in the Japanese population was clarified for the first time thr

47 i associated with atrial fibrillation in the Japanese population, we performed a genome-wide associat

48 or type 1 diabetes (T1D) for the Swedish and Japanese populations, we determined that T1D risk-associ

49 typing CNVs in the CEPH, Yoruba, and Chinese-Japanese populations, we estimated that at least 11% of

50 frican American, European American (EA), and Japanese populations, we have identified a novel polymor

51 ncer cases and 12 558 non-cancer controls of Japanese populations, we identified a susceptibility loc

52 hearing loss families from both American and Japanese populations were screened for mutations.

53 tylhydrolase activity is absent in 4% of the Japanese population, which suggests that it could be a c

54 lear distinction between the Chinese and the Japanese populations, with the Japanese population being

55 e I (HTLV-I) infection was investigated in a Japanese population within an area in which HTLV-I infec